Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 387.00
+7.35 (1.94%)
Nov 11, 2026, 1:14 PM IST
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 50.36 billion as of November 10, 2026. Its market cap has increased by 1.69% in one year.
Market Cap
50.36B
Enterprise Value
51.92B
Revenue
1.74B
Global Rank
n/a
Country Rank
n/a
PE Ratio
86.56
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 50.36B, an increase of 144,618.97%. That is a compound annual growth rate of 33.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 50.36B | 4.46% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 117.25B |
| Strides Pharma Science | 92.38B |
| Aarti Pharmalabs | 83.55B |
| Sun Pharma Advanced Research Company | 68.41B |
| Innova Captab | 61.17B |
| Orchid Pharma | 52.94B |
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |